BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190607
DTSTAMP:20260405T225815
CREATED:20190201T195534Z
LAST-MODIFIED:20190214T191645Z
UID:2275-1559520000-1559865599@carb-x.org
SUMMARY:2019 BIO International Convention
DESCRIPTION:The BIO International Convention (BIO) attracts 16\,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery\, biomanufacturing\, genomics\, biofuels\, nanotechnology and cell therapy. \nThe key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering\, exposure to industry thought-leaders with over 500 education sessions at your fingertips\, and unparalleled networking opportunities with 16\,000+ attendees from 67 countries. \nSee the schedule here.
URL:https://carb-x.org/event/2019-bio-international-convention/
LOCATION:Philadelphia Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190604T133000
DTEND;TZID=Europe/Berlin:20190604T150000
DTSTAMP:20260405T225815
CREATED:20190528T155449Z
LAST-MODIFIED:20190528T160555Z
UID:3052-1559655000-1559660400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl. \nDespite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nSpeakers:\nCarl Balibar\, Principal Scientist\, Merck Research Laboratories \nModerator:\nBenjamin Blasco\, Discovery Senior Project Manager\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials-session-2/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260405T225815
CREATED:20190226T195721Z
LAST-MODIFIED:20190305T211145Z
UID:2461-1559692800-1559865599@carb-x.org
SUMMARY:Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium
DESCRIPTION:Panelists members include Kevin Outterson\, Executive Director of CARB-X\, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel. \n\n\n\nThis panel will discuss the use of public-private partnerships as models for stimulating innovation through sponsored research and development. The panelists will provide overviews of several partnership-enabled consortia and accelerators\, including BARDA’s new Division of Research\, Innovation\, and Ventures and their participation in the partnership\, Combating Antibiotic Resistant Bacteria\, and\, as well as DoD’s Medical CBRN Defense Consortium and Medical Technology Enterprise Consortium. Presenters will discuss their organization’s background and structure\, as well as their unique mechanisms for engaging the research community to solve significant public health and biomedical challenges. \n\n\n\nThe Symposium will focus on two separate tracts. The first\, “Medical Support to the Warfighter\,” will connect businesses and university researchers with military and other federal agencies that require or purchase medical supplies\, equipment\, devices\, pharmaceuticals\, information technology and services\, or fund medical-related research and development. \nThe second tract\, “Biomedical and Biodefense Support to the Warfighter\,” will focus on establishing dialogue between industry and academia-based technology innovators and military and government officials to address the future biomedical and biodefense needs of the military and our nation. \n\nTo learn more\, please click here.
URL:https://carb-x.org/event/medical-biomedical-biodefense-support-to-the-warfighter-symposium/
LOCATION:The Friday Conference Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190611T100000
DTEND;TZID=America/New_York:20190611T110000
DTSTAMP:20260405T225815
CREATED:20190517T135538Z
LAST-MODIFIED:20190528T155538Z
UID:3015-1560247200-1560250800@carb-x.org
SUMMARY:Live Webinar: Funding Opportunities for Antimicrobial Drug Development from the Cystic Fibrosis Foundation
DESCRIPTION:Interested in new funding opportunities for infection drug development?\nThe Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11\, from 10:00am – 11:00am ET\, to introduce their new Infection Research Initiative. \nDuring the webinar\, Dr. Ann Field\, Senior Director of Drug Discovery and Development at the Cystic Fibrosis Foundation\, will discuss potential funding opportunities for therapeutic development of anti-infectives in key organisms of interest for CF infections.  The presentation will be followed by an interactive Q&A session. \nWebinar Summary\nLearn about funding opportunities for infection drug development through the Cystic Fibrosis Foundation. This webinar will include: \n\nOverview of the CF Foundation and the recently announced Infection Research Initiative\nCF Foundation interest in supporting therapeutic development for anti-infectives in key organisms of interest for CF infections\nTherapeutic Development Award Process and collaboration opportunities\n\nTo join this webinar\, please register here. \nIf you have questions or comments\, please let us know. Feel free to email your questions or comments to Raj Shetty at dshetty@carbx.org before the webinar\, or save them for the live Q&A session following the presentation.  We look forward to hearing from you!
URL:https://carb-x.org/event/webinar-funding-opportunities-for-antimicrobial-drug-development-from-the-cystic-fibrosis-foundation/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190611T170000
DTEND;TZID=Europe/Berlin:20190611T183000
DTSTAMP:20260405T225815
CREATED:20190528T160224Z
LAST-MODIFIED:20190528T160702Z
UID:3058-1560272400-1560277800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, William J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy\, will introduce experimental design of animal models for antimicrobial research. He will discuss questions such as 1) Where to start and what model to use? 2) Are animal models of bacterial infection reflective of the clinical condition? 3) Are in vivo animal model results predictive of clinical efficacy? The presentation will be followed by a Q&A session moderated by Peter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec. \nSpeakers:\nWilliam J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy \nModerator:\nPeter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-development-and-use-of-in-vivo-models-for-infectious-disease-research/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190625
DTSTAMP:20260405T225815
CREATED:20190201T200421Z
LAST-MODIFIED:20190214T191858Z
UID:2280-1560988800-1561420799@carb-x.org
SUMMARY:ASM Microbe 2019
DESCRIPTION:Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties\, discover cutting-edge research in the poster and oral presentations\, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.
URL:https://carb-x.org/event/asm-microbe-2019/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190624T071500
DTEND;TZID=America/Los_Angeles:20190624T081500
DTSTAMP:20260405T225815
CREATED:20190207T143629Z
LAST-MODIFIED:20190214T192046Z
UID:2360-1561360500-1561364100@carb-x.org
SUMMARY:ASM Microbe Breakout Session - Enabling Academia to Fill the Discovery Gap
DESCRIPTION:Presentations developed in cooperation with GARDP\, CARB-X\, and REPAIR Impact Fund. \nAntimicrobial resistance (AMR) continues to be a major problem that is not being addressed adequately by the pharmaceutical industry. Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session\, drug discovery efforts originating from academic laboratories will be discussed. The importance of collaborative efforts will be emphasized.
URL:https://carb-x.org/event/enabling-academia-to-fill-the-discovery-gap-developed-in-cooperation-with-gardp-carb-x-and-repair-impact-fund/
LOCATION:Moscone Center\, 747 Howard Street\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190629
DTSTAMP:20260405T225815
CREATED:20190206T170153Z
LAST-MODIFIED:20190227T152450Z
UID:2342-1561420800-1561766399@carb-x.org
SUMMARY:International Council of Academies of Engineering and Technological Sciences (CAETS) Conference
DESCRIPTION:Speakers include Kevin Outterson\, Executive Director of CARB-X. \nThe Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and Technological Sciences (CAETS) in 2019. CAETS in a independent non-political\, non-governmental international organization of engineering and technological science academies worldwide. The conference will focus on what engineering and technological science has accomplished in the last 100 years as well as future challenges\, focusing on the topics of Health\, Energy\, Affordable Living\, Superintelligens and Distrubution of Resources. The conference will focus on how engineering and technological science can morph into the future and contribute to solutions. \n 
URL:https://carb-x.org/event/international-council-of-academies-of-engineering-and-technological-sciences-caets-conference/
LOCATION:Stockholm\, Stockholm\, Sweden
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190626T103000
DTEND;TZID=America/New_York:20190626T113000
DTSTAMP:20260405T225815
CREATED:20190620T134850Z
LAST-MODIFIED:20190620T134850Z
UID:3143-1561545000-1561548600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
DESCRIPTION:In this webinar\, Dr Manica Balasegaram\, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan\, and share GARDP’s updated strategy. Following his presentation\, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz\, GARDP’s Director of External Affairs. \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-find-out-how-gardp-is-redoubling-its-efforts-to-accelerate-the-development-and-delivery-of-new-and-improved-antibiotics/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR